Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Relationship between Tumor Development and Sarcoidosis in Aspects of Carcinogenesis before and after the Onset of Sarcoidosis. | Medicina (Kaunas) | 2022 | 35744031 | PubTator, text mining | PubMed |
| Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development. | Front Genet | 2022 | 35734437 | PubTator, text mining | PubMed |
| FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma. | J Immunol Res | 2022 | 35733916 | PubTator, text mining | PubMed |
| Uterine Natural Killer Cells: A Rising Star in Human Pregnancy Regulation. | Front Immunol | 2022 | 35720413 | PubTator, text mining | PubMed |
| Recent Advancements in Poor Graft Function Following Hematopoietic Stem Cell Transplantation. | Front Immunol | 2022 | 35720412 | PubTator, text mining | PubMed |
| Uncovering the Mast Cell Response to Mycobacterium tuberculosis. | Front Immunol | 2022 | 35720353 | PubTator, text mining | PubMed |
| One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia. | Front Immunol | 2022 | 35720276 | PubTator, text mining | PubMed |
| Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator. | Front Oncol | 2022 | 35719962 | PubTator, text mining | PubMed |
| Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma. | Front Oncol | 2022 | 35719911 | PubTator, text mining | PubMed |
| Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis. | Ren Fail | 2022 | 35713363 | PubTator, text mining | PubMed |
| The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma. | Biomed Res Int | 2022 | 35711526 | PubTator, text mining | PubMed |
| The Role of Crosstalk of Immune Cells in Pathogenesis of Chronic Spontaneous Urticaria. | Front Immunol | 2022 | 35711438 | PubTator, text mining | PubMed |
| NK Cells, Monocytes and Macrophages in HIV-1 Control: Impact of Innate Immune Responses. | Front Immunol | 2022 | 35711433 | PubTator, text mining | PubMed |
| Remission of liquid tumors and SARS-CoV-2 infection: A literature review. | Mol Ther Oncolytics | 2022 | 35702422 | PubTator, text mining | PubMed |
| Role of CD47 in tumor immunity: a potential target for combination therapy. | Sci Rep | 2022 | 35697717 | PubTator, text mining | PubMed |
| SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma. | Front Genet | 2022 | 35692837 | PubTator, text mining | PubMed |
| Multiomics Data Analysis and Identification of Immune-Related Prognostic Signatures With Potential Implications in Prognosis and Immune Checkpoint Blockade Therapy of Glioblastoma. | Front Neurol | 2022 | 35669882 | PubTator, text mining | PubMed |
| Identification of hub genes and molecular pathways in human T-lymphotropic virus type 1 associated diseases using protein-protein interactions networks. | Iran J Microbiol | 2022 | 35664724 | PubTator, text mining | PubMed |
| MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer. | Front Genet | 2022 | 35664337 | PubTator, text mining | PubMed |
| Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis. | Front Immunol | 2022 | 35663977 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=45